Abstract:We read with interest the study by van den Broek and colleagues published in the recent issue of Endoscopy 1. The authors examined whether the use of probe-based confocal laser endomicroscopy (pCLE) may increase the efficiency of surveillance of patients with ulcerative colitis. In the study, 48 visible lesions and 87 random areas in 22 patients with ulcerative colitis were evaluated by real-time narrow-band imaging (NBI) and high-definition endoscopy (HDE). Fluorescein-enhanced pCLE was performed prior to biopsy. The outcome measures were the feasibility and the diagnostic accuracy of pCLE. They showed that the sensitivity, specificity, and accuracy of pCLE were 65 %, 82 %, and 81 %, whereas these figures were 100 %, 89%, and 92 % for real-time endoscopic diagnosis with NBI and HDE. From these results, the authors concluded that pCLE for ulcerative colitis surveillance is feasible and has reasonable diagnostic accuracy. We agree with the authors that taking random biopsies is time-consuming and of doubtful efficiency. We have previously shown that pit pattern diagnosis might be useful in improving the efficiency of surveillance for ulcerative colitis 2. Considering that pCLE is, in fact, in vivo histology and has shown high agreement with true histopathology, it may be possible that pCLE substitutes random biopsies and obviates targeted biopsies. However, in the van den Broek study, there are major issues that need to be discussed before their conclusion can be drawn. The first point concerns the management of lesions that are indefinite for dysplasia. Van den Broek used the Vienna criteria for histopathological classification 3. The Vienna criteria were established to develop common worldwide terminology for gastrointestinal epithelial neoplasia, including esophageal, gastric, and colorectal lesions. Neoplastic lesions are categorized as Category 3, Category 4 or Category 5. The van den Broek study used these categories to classify biopsied lesions. This classification is used for neoplastic lesions in general; however, it is well known that histopathological classification of specimens in ulcerative colitis needs special attention because histopathological diagnosis is sometimes very difficult due to the inflammatory changes. This makes it difficult to make a distinction between low-grade dysplasia and non-neoplastic lesions with inflammation. This is why Riddell et al. divided the classification of “indefinite for dysplasia” into three different categories – probably negative, unknown, and probably positive, each of which needs a different follow-up strategy 4. Riddell reported that patients with “unknown” or “probably positive for dysplasia” need short-interval follow-up 4. Therefore, it is important not to miss lesions with “indefinite for dysplasia (unknown or probably positive)” during surveillance. As the histological distinction between low-grade dysplasia and indefinite for dysplasia is sometimes difficult, it seems that pCLE can hardly distinguish between these two lesion types. However, in the van den Broek study, lesions that were “indefinite for dysplasia” were excluded because the study focused only on neoplastic lesions. It would be of interest to determine whether or not pCLE can identify lesions classified as “indefinite for dysplasia.” The next point is the outcome measure of feasibility. Van den Broek et al. expressed the feasibility of pCLE as pCLE imaging time required, percentage of imaging time with clear pCLE histology, and pCLE video quality as rated by two endoscopists. However, the pCLE imaging time required may not reflect the total time of examination directly and we believe that the most important issue is the total time needed to complete the surveillance colonoscopy in each individual. To compare the efficacy of surveillance between target biopsy and random biopsy, a nationwide randomized controlled study is ongoing in Japan 5. In this trial, the total time of the examination is included as the outcome measure. We believe this prospective trial will clarify the difference between target biopsy and random biopsy in terms of total time needed for the examination. We believe that the van den Broek study, which was undertaken by a leading group in the world in this field, has shown very important findings. However, to evaluate the efficacy of pCLE, we believe that the above issues need to be discussed further.

The value of assessing deep disease healing by probe‐based confocal laser endomicroscopy and histology for long‐term prognosis of ulcerative colitis

Evaluation of confocal laser endomicroscopy on pathological changes of intestinal mucosa repairing for patients with ulcerative colitis

P318 Performance of rectosigmoidoscopy and rectoscopy to assess endoscopic and histological healing in ulcerative colitis

DOP21 Histo-endoscopic remission (HEMR) Predicts Future Relapse in Patients with Ulcerative Colitis and is Associated with Lower Colectomy Risk

Efficacy of probe-based confocal laser endomicroscopy for surveillance in ulcerative colitis endomicroscopy for ulcerative colitis surveillance

P356 Long-term outcome of UC patients in clinical remission with different level of mucosal activity: real world, retrospective, multicontinental study

P431 Assessing intestinal barrier healing by fusing ultra-high magnification endoscope and automated spatial multispectral imaging analysis in PSC-colitis patients

Histologic healing and clinical outcomes in ulcerative colitis

Imbalanced Mucosal Microcirculation in the Remission Stage of Ulcerative Colitis Using Probe-Based Confocal Laser Endomicroscopy

A Prospective Study on Second-Generation Colon Capsule Endoscopy to Detect Mucosal Lesions and Disease Activity in Ulcerative Colitis (with Video).

Confocal laser endomicroscopy for the differential diagnosis of ulcerative colitis and Crohn’s disease: a pilot study

Development and validation of a novel criterion of histologic healing in ulcerative colitis defined by inflammatory cell enumeration in lamina propria mucosa: A multicenter retrospective cohort in China

Histologic assessments in ulcerative colitis: the evidence behind a new endpoint in clinical trials

P412 Faecal Calprotectin as a predictor of endoscopic and histologic remission in patients with Ulcerative Colitis

Non-invasive evaluation of mucosal healing by intestinal ultrasound or fecal calprotectin is efficient in Crohn's disease: A cross-sectional study

Accuracy of Faecal Immunochemical Test to Predict Endoscopic and Histological Healing in Ulcerative Colitis: A Prospective Study Based on Validated Histological Scores.

P246 Histologic remission is an important therapeutic target in patients who achieve endoscopic remission of ulcerative colitis

Confocal Laser Endomicroscopy Can Improve the Diagnosis Rate and Range Assessment of Patients with Conflicting Chronic Atrophic Gastritis Results of White Light Endoscopic and Pathological Diagnosis

Fecal Immunochemical Test Predicts Histological Healing in Ulcerative Colitis: A Prospective Study Using the Geboes Score and Nancy Index

P231 Impact of the depth of mucosal healing on the burden of ulcerative colitis : a cross-sectional study

P408 Complete endoscopic healing, the future therapeutic target in Crohn's disease? Results of a prospective multicenter study